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Abstract
Background: Cardiac dysfunction in boys with Duchenne muscular dystrophy (DMD) is a leading cause of death.
Cardiac resynchronization therapy (CRT) has been shown to dramatically decrease mortality in eligible adult
population with congestive heart failure. We hypothesized that mechanical dyssynchrony is present in DMD
patients and that cardiovascular magnetic resonance (CMR) may predict CRT efficacy.
Methods: DMD patients (n = 236) were stratified into 4 groups based on age, diagnosis of DMD, left ventricular
(LV) ejection fraction (EF), and presence of myocardial fibrosis defined as positive late gadolinum enhancement
(LGE) compared to normal controls (n = 77). Dyssynchrony indices were calculated based on timing of CMR
derived circumferential strain (ecc). The calculated indices included cross-correlation delay (XCD), uniformity of strain
(US), regional vector of variance (RVV), time to maximum strain (TTMS) and standard deviation (SD) of TTMS.
Abnormal XCD value was defined as > normal + 2SD. US, RVV, TTMS and SD were calculated for patients with
abnormal XCD.
Results: There was overall low prevalence of circumferential dyssynchrony in the entire DMD population; it
increased to 17.1% for patients with abnormal EF and to 31.2% in the most advanced stage (abnormal EF with
fibrosis). All but one DMD patient with mechanical dyssynchrony exhibited normal QRS duration suggesting
absence of electrical dyssynchrony. The calculated US and RVV values (0.91 ± 0.09, 1.34 ± 0.48) indicate disperse
rather than clustered dyssynchrony.
Conclusion: Mechanical dyssynchrony is frequent in boys with end stage DMD-associated cardiac dysfunction. It is
associated with normal QRS complex as well as extensive lateral fibrosis. Based on these findings, it is unlikely that
this patient population will benefit from CRT.
Background
In patients with New York Heart Association (NYHA)
class III, ambulatory class IV systolic heart failure (HF)
and recently class I and II, with electrocardiographic evi-
dence of ventricular dyssynchrony, cardiac resynchroni-
zation therapy (CRT) improves quality of life and
functional status, reduces heart failure-related hospitali-
zations, and prolongs survival [1-4]. While current indi-
cations are based on QRS duration > 120 ms, HF
patients with narrow QRS complexes have been investi-
gated for the presence of mechanical dyssynchrony. In
this population, the prevalence of dyssynchrony is
present though at a lower frequency compared to
patients with prolonged QRS. Accordingly, in several
small pilot studies [5-8] these patients appear to benefit
from CRT, although a large multicenter randomized
trial did not meet its primary endpoint [9]. In the pedia-
tric heart failure population there is even less data and
there are no large retrospective or prospective trials in
reference to CRT [10].
A major cause of pediatric HF, Duchenne muscular
dystrophy (DMD) is an X-linked recessive disorder char-
acterized by disruption of the dystrophin protein. The
resulting cell membrane degradation in skeletal and car-
diac muscle tissue [11-13] leads to a cascade of inflam-
mation, edema, necrosis and fatty replacement [14-17].
This ultimately results in the development of myocardial
fibrosis. Although the extent of involvement varies,
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of age in essentially all DMD patients. Current thera-
peutic options for DMD associated HF are limited with
no established standard of care for medical or device
interventions. This study sought to determine the feasi-
bility of CRT in the DMD population, most of whom
have normal QRS complexes. We evaluated the preva-
lence and character of mechanical dyssynchrony using
the cross correlation delay (XCD) method, a highly
objective, automatable dyssynchrony parameter on
tagged cardiovascular magnetic resonance (CMR) [18].
Methods
Study Population
This is a retrospective cohort analysis and was con-
ducted with the approval of the Institutional Review
Board at the Cincinnati Children’s Hospital Medical
Center. Patients were identified using the clinical CMR
database at the Heart Institute at Cincinnati Children’s
Hospital Medical Center from September 2005 to
March 2009. This study included all DMD patients >
7 years of age who had previously undergone clinical
CMR studies. Subjects < 7 years of age were excluded in
order to eliminate the need for sedation to undergo the
CMR study. A diagnosis of DMD was confirmed by a
skeletal muscle biopsy and/or a DNA analysis demon-
strating a characteristic dystrophin mutation.
Genetic testing was performed at Athena Diagnostics,
Inc. or Medical Genetics Laboratories, Baylor College of
Medicine (prior to 2006) and at Emory University
Genetics Laboratory, Atlanta, Georgia (since 2006).
Subject groups
DMD patients (n = 236) were stratified into 4 groups
based on age, left ventricular (LV) ejection fraction (EF),
presence of myocardial fibrosis defined as positive late
gadolinum enhancement (LGE) and compared to nor-
mal controls (Figure 1).
CMR and HARP
® Analyses
Clinical CMR studies were conducted on either a Sie-
mens 3 Tesla Trio (Siemens Medical Solutions, Malvern,
PA/Erlangen, Germany) or on a 1.5 Tesla GE Signa
Excite (General Electric Healthcare; Milwaukee, WI).
The type and field strength of MRI system was based
solely on clinical availability and scheduled independent
of the patient’s clinical status or prior type or field
strength of the first study.
Routine cardiac functional imaging was performed with
a retrospectively vectorcardiographic (VCG) gated, seg-
mented Steady State Free Precession (SSFP) technique
after localized shimming and/or frequency adjusting.
Subjects were breath-held as tolerated; for those subjects
who could not adequately breath-hold, a free breathing
technique with multiple signal averaging was used. Stan-
dard functional imaging included a short axis stack of
cine SSFP images from cardiac base to apex; the short
axis was prescribed as the perpendicular plane to the left
ventricular long axis in 2 and 4 chamber views as per
previously published protocols. Typical scan parameters
were as follows: FOV = 32-38 cm, slice thickness =
5-6 mm, gap = 1-2 mm, NEX = 2 (breath hold; 4-5 for
free breathing), TE/TR = 1.4/2.8 (Siemens), TE/TR = 2.0/
4.0 (GE), in-plane resolution = 1.2- 2.2 mm. Minimums
of 12 slices were performed with 20 phases/slice.
Tagged cine CMR images were acquired in the short
axis of the mid ventricle at the level of the papillary mus-
cles based on the four chamber view using an ECG-
triggered segmented k-space fast gradient echo sequence
with spatial modulation of magnetization in orthogonal
planes. Grid tag spacing was 8 mm. The scan parameters
used were: TE/TR = 3/15 ms. field of view = (30-32) ×
(25-26) cm, slice thickness = 6 mm, acquisition matrix =
256 × 144, flip = 20°, views per segments = 8-9. Only good
quality tagged cine MRIs were included for analysis (con-
firmed by 2 independent expert readers: NA and KNH).
Late gadolinum enhancement (LGE)
LGE imaging was performed on DMD patients when
intravenous access was obtained (n = 121); no LGE ima-
ging was performed in the control group. LGE imaging
was performed via a FLASH inversion sequence recov-
ery protocol 10 min after 0.2 mmol/kg gadolinium
diethylenetriamine penta-acetic acid (Gd-DTPA) injec-
tion. LGE imaging was considered positive if any area of
the mid-myocardium showed hyperenhancement as
assessed by consensus of 3 readers (KNH, WMG, WM)
ECG Analysis
Standard 12 lead ECG was obtained in all patients; QRS
duration was measured manually.
Data Analysis
Left ventricular function and volumes
Left ventricular volumes, mass and global function were
assessed via standard planimetry techniques using semi
automated computer software (QMASS v.6.1.5, Medis
Medical Imaging Systems, Netherlands) by expert read-
ers (KNH and WMG). Left ventricular stroke volume
was also determined by analysis of cine velocity encoded
phase contrast gradient echo (GRE) sequence of the
ascending aorta via Medis QFLOW
® platforms for inter-
nal validation of the stroke volume determined by ven-
tricular planimetry. Ventricular volumes, mass, and
ejection fraction were tabulated for each subject.
Myocardial Strain Analysis
As previously described, tagged images from two times
points of the mid-ventricle were analyzed using the
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que [19-23]. Details of circumferential strain (εcc)a n a l y -
sis have been previously described [24,25]. Only the
mid-ventricular slice was analyzed secondary to [24,25]
the limited reproducibility of the analysis of the basal
and apical slices. The regional (absolute value and time
to peak) and global εcc data was exported to a spread-
sheet file for analysis.
Late Gadolinum Enhancement Analysis
LGE transmural extent was calculated as the ratio of
myocardial LGE thickness to total wall thickness. It was
expressed in 2 categories: <50%, and >50%.
Dyssynchrony Assessment
εcc vs. time curves from 24 sub-regions at the mid ven-
tricular level were used. Six regional εcc curves were
constructed by taking the average of four adjacent sub-
regions to represent the segments 7-12 in the AHA 17
segment heart model. Sub-regional εcc curves were used
in the analysis of spatial dyssynchrony quantified by
Uniformity of Strain (US), and Regional Vector of
Variance (RVV). Regional εcc curves were used in the
analysis of temporal dyssynchrony quantified by cross-
correlation delay (XCD), time to maximum strain
(TTMS) and the standard deviation of TTMS (STD).
Data were analyzed using custom developed software
using IDL (IDL 6.2, ITT Visual Information Solutions,
Boulder, CO).
(1) The cross-correlation delay (XCD)(18) between
two curves was computed by shifting one curve in time
relative to the other curve and computing the normal-
ized correlation between the curves for each time shift.
The time shift between the two curves that resulted in
the maximum correlation value was deӿned as the tem-
poral delay between the two curves. A temporal delay
was computed between the anterior and inferior seg-
ments (XCD 7-10), the anteroseptal and inferolateral
segments, (XCD 8-11) and the inferoseptal and antero-
lateral segments, (XCD 9-12) and the reported XCD was
the maximum of these three delays. As normal values
for above variables have not been published, we used
Figure 1 Group Stratification. DMD patients (n = 236) were stratified into 4 groups based on age, diagnosis of DMD, left ventricular (LV)
ejection fraction (EF), and presence of myocardial fibrosis defined as positive late gadolinium enhancement(LGE). DMD and compared to normal
controls.
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cative for dyssynchrony.
(2) Time to maximum strain (TTMS) was calculated
as follows: for each regional εcc curve, the time from the
onset of QRS to the maximum absolute εcc (Tmax)w a s
determined. Then TTMS was calculated as the differ-
ence between the shortest and the longest Tmax i.e. the
time difference between the earliest and the latest time
at which a region reaches its maximum strain.
(3) The standard deviation (STD) of Tmax is calculated
for each of the six regions.
In addition to the above, we evaluated two additional
indices of “global dyssynchrony” differentiating between
“clustered” and “dispersed “dyssynchrony (Figure 2) [26].
(1) Uniformity of Strain (US) [27] was derived by sub-
jecting the spatial plot of sub-regional strains at end sys-
tole (defined by the time at which mean εcc reached
maximum) to Fourier analysis. If all sub-regions shorten
simultaneously (synchronously), the plot appears as a
straight line, with power only in the zero-order Fourier
term (A0), whereas regionally clustered dyssynchrony
generates an undulating plot with higher power in the
first-order term (A1). The US index is defined as
AA A 0
2
0
2
1
2 2 + () .T h eU Si n d e xi sz e r of o rd y s s y n -
chronous contraction and 1 for perfectly synchronous
contraction.
(2) Regional vector of variance (RVV) [28] was derived
by representing the εcc value of the n
th sub-region at a
given time point by a vector with magnitude εcc (n) and
phase 2πn / 2 4 ,( n=1 . . 2 4 ) .R V Vw a sc a l c u l a t e da st h e
vector sum of all εcc (n) giving a zero value for perfect
synchrony. The maximum value of RVV depends on the
number of segments analyzed. For 24 segments the
maximum RVV value is 7.66.
Patients with abnormal XCD were presumed to have
mechanical dyssynchrony and TTMS, SD, RVV, US
were also calculated and compared for groups A-E.
Statistical Analysis
Results are expressed as mean ± SD for continuous data
and as percentages and numbers for categorical data.
Pearson’s correlation coefficients were calculated to
assess for linear relationships between relevant variables.
Dunnett test was used to compare groups (B-E) to the
control group (A) on variables of interest.
Results
236 consecutive patients with DMD where evaluated.
Patient demographic, EF, mass volume ratio and mean
values for all dyssynchrony indices are presented in
Table 1. All the normal controls had absolute εcc
greater than 17 and all DMD patients had absolute εcc
less than 17. In DMD patients but not normal con-
trols, strain declined with age as previously described
[24].
LGE was observed in group E only, involving antero-
lateral and inferolateral segments, with extent of
enhancement over 50% of wall thickness (Figure 3).
QRS duration
Summary statistics for QRS duration by groups are
g i v e ni nT a b l e1 .N e i t h e rl e f tn o rr i g h tb u n d l eb r a n c h
block morphology was observed in our study group.
There were 3 boys (1 in each group A, D and E) with
QRS duration over 120 ms consistent with nonspecific
intraventricular conduction delay.
Dyssynchrony
Comparison of boys with identified dyssynchrony to
control group is presented in Table 2. We defined XCD
to be the largest of the three XCD (XCD 7-10, XCD
8-11 or XCD 9-12) measurements. There were 9 (3.8%)
b o y s( 3i ng r o u pC ,1i ng r o u pDa n d5i ng r o u pE )
with abnormal XCD, defined as XCD larger than
79.4 ms (calculated as mean + 2SD of XCD of normal
control) In these 9 patients, TTMS was 111.2 ± 39.5 ms,
RVV was 1.3 ± 0.5, STD was 45.6 ± 18.1, US was 0.9 ±
0.10 and QRS duration was 98.2 ± 15.3 ms. Only 1 of
those 9 boys had a QRS > 120 ms. One-way ANOVA
model comparing dyssynchrony indices in 9 DMD boys
with mechanical dyssynchrony to those of control group
A (n = 77) showed statistically significant differences in
all indices except for QRS duration (p = 0.2825). In
addition, RVV index was borderline significant (p =
0.0538) as compared to the control group. It needs to
be noted that despite statistical differences US and RVV
values in boys with dyssynchrony are suggestive of
nearly “net” synchronous contraction (disperse rather
than clustered dyssynchrony) (Figure 2).
Figure 2 Schematic representation of clustered (A) and
disperse (B) dyssynchrony. Depending how dyssynchrony is being
indexed, Results could be the same for both situations, despite
markedly different impact on dsyynchrony. In example B, there is a
“net” synchronous contraction. Uniformity of Strain (US) and
Regional Variance of Strain (RVV) are vector derived indices
differentiating clustered from dispersed dyssynchrony. Adapted
from: Lardo, A. C. et al. J Am Coll Cardiol 2005;46:2223-2228.
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This study demonstrated that there is a significant preva-
lence of mechanical ventricular dyssynchrony (17%) in
D M Dp a t i e n t sw i t hE F<5 5 % .A d d i t i o n a l l y ,t h ep r e v a -
lence of dyssynchrony was greater in patient subsets with
more advanced cardiac disease (low EF and fibrosis).
This is the first study to our knowledge to use an
automated MRI derived cross correlation technique for
assessment of mechanical dyssynchrony. It is also the
first study to assess prevalence and characteristics of
dyssynchrony in a large DMD patient population. Pre-
vious application of the XCD method utilized echocar-
diography [29] data. Subsequently, CMR (phase
contrast) [30,31] was found to be superior for measuring
time to peak dyssynchrony parameters for discriminat-
ing between subjects with and without dyssynchrony.
Circumferential strain is an established CMR method of
dyssynchrony assessment, Han et al evaluated circumfer-
ential myocardial strain in cardiomyopathy with and
without left bundle branch block; these authors assessed
opposing wall delays, and reported values within the
range of XCD values in our patient population [32]. The
current study, to our knowledge is also the first to assess
circumferential dyssynchrony by XCD in a narrow QRS
patient population.
Boys with DMD do not fulfil classic adult derived cri-
teria for CRT: QRS complex is narrow in 97% of the
population, EF is generally greater than 35%, and due to
the nature of the disease, NYHA functional class could
not be assessed. These barriers, combined with compel-
ling and devastating disease progression, make it even
more important to develop sensitive tools to create pre-
diction models as to likelihood of success with CRT in
all or a distinct subset of this patient population. In this
s t u d yw ed e m o n s t r a t e dal o wp r e v a l e n c eo fd y s s y n -
chrony in the overall population of boys with DMD
using cross-correlation delay; but the prevalence
increased to 17.1% for patients with abnormal EF
(groups D and E) and to 31.2% in the most advanced
stage (group E). All but one of the boys with DMD and
mechanical dyssynchrony exhibited normal QRS dura-
tion suggesting absence of electrical dyssynchrony. Only
weak relationships were found between dyssynchrony
Table 1 General Characteristic by Group
Parameter Group
A
(n = 77)
B
(n = 90)
C
(n = 111)
D
(n = 19)
E
(n = 16)
Age 13.9 ± 8.9 8.5 ± 0.9** 12.9 ± 2.8 15.0 ± 3.9 17.3 ± 5.4**
LVEF (%) 64.6 ± 5.9 65.0 ± 4.8 64.4 ± 5.8 49.4 ± 6.6** 36.5 ± 12.2**
XCD
a 45.6 ± 16.9 35.3 ± 16.6 38.2 ± 19.8 52.2 ± 22.4 73.0 ± 41.9
US_max 0.97 ± 0.04 0.98 ± 0.03 0.97 ± 0.03 0.97 ± 0.04 0.92 ± 0.08**
TTMS 78.2 ± 31.8 65.4 ± 22.9** 71.2 ± 24.0 95.1 ± 19.6** 111.4 ± 33.0**
RVV_max 0.95 ± 0.57 1.03 ± 0.55 1.13 ± 0.57 1.03 ± 0.51 1.34 ± 0.57**
STD_peak 31.7 ± 12.0 26.7 ± 8.4** 29.6 ± 9.7 36.5 ± 6.9 46.1 ± 16.6**
QRS 92.8 ± 11.4
1 85.1 ± 7.8** 86.6 ± 8.0** 86.1 ± 13.4 97.1 ± 12.9
εcc -18.2 ± 4.5 -14.2 ± 1.4** -13.2 ± 2.0** -10.7 ± 2.1 -7.0 ± 2.8
Figure 3 Late gadolinum enhancement (LGE).L G Ei m a g e so fa
representative patient from group E. Note predominantly transmural
enhancement involving anterolateral and inferolateral segments in
apical four chambers and short axis views.
Table 2 Abnormal XCDs vs. the control
Parameter Group
Control
(n = 77)
Abnormal XCDs
(n = 9)
Age 13.9 ± 8.9 16.7 ± 5.0
LVEF (%)
(min, max)
64.6 ± 5.9 43.9 ± 16.7**
LVRI 0.71 ± 0.19 0.66 ± 0.21
XCD
a 45.6 ± 16.9 116.5 ± 20.5**
Presence of LGE 0 (0.0%) 4 (57.1%)**
US_max 0.97 ± 0.04 0.91 ± 0.09**
TTMS 78.2 ± 31.8 111.2 ± 39.5**
RVV_max 0.95 ± 0.57 1.34 ± 0.48
STD_peak 31.7 ± 12.0 47.6 ± 18.1**
QRS 92.8 ± 11.4
1 98.2 ± 15.3
**P < 0.05 as compared to the control group (A) using Dunnett test.
aXCD = maximum of (XCD 1-4, XCD 2-5 and XCD 3-6).
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with low EF. Of interest, in those with dyssynchrony,
US and RVV values indicate t h ep r e s e n c eo fd i s p e r s e
rather than clustered dyssynchrony. Disperse dyssyn-
chrony patients would not be expected to respond
favourably to CRT (Figure 2).
Location of scar tissue is concerning as well, as most
common LGE location was in the inferolateral segments.
In patients with ischemic CMP, inferolateral scar invol-
ving over 50% of wall thickness virtually excluded
improvement with CRT [33], as did total scar volume of
over 15% [34,35]. We could not assess total scar volume
in our study as only 3 short axis slices were acquired for
LGE assessment. Even if left ventricular lead was
implanted before the development of extensive inferolat-
eral fibrosis, it is possible that disease progression in
that segment would diminish efficacy of CRT over time.
Do these barriers preclude the possibility that LV
pacing might benefit these patients? The favourable
effect of LV pacing on the failing heart’s contractility
and external constraint may help to slow the progres-
sion of disease. LV pacing also reduces the work per-
formed by the LV as well as beat to beat transmural
stress. It is possible that with chronic treatment, a small
change in detrimental physiology might realize clinical
benefit. Further studies are warranted to evaluate these
hypotheses.
Study Limitations
We had a relatively small number of patients with low
EF and mechanical dyssynchrony; all had advanced
DMD associated cardiac disease (2 from group D and 7
from group E). All of the patients in group E had exten-
sive fibrosis, obviously due to selection bias less
advanced cases were missed. To prove that our analysis
is valid, response to biventricular pacing would be most
optimal. Tag analysis was performed up to 3rd frame
after peak systole, (due to tag fading), it is possible that
very dyssynchronous segments were missed, however
the prevalence of mechanical dyssynchrony in boys with
most advanced disease was similar to that seen in adult
heart failure patients.
Conclusions
Mechanical dyssynchrony was seen in 17.1% of DMD
boys with EF < 55% and in 31.2% of boys with most
advanced stages of disease (low EF and fibrosis); how-
ever, the observed dyssynchrony was dispersed in nat-
ure. It remains to be seen if those patients would
respond to CRT.
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